Superorganism
Superorganism is an early-stage venture capital firm based in New York, dedicated to supporting biodiversity-driven startups. Founded in 2022, the firm focuses on investing in entrepreneurs who tackle critical challenges at the intersection of technology, markets, and biodiversity. Their mission emphasizes "biocapital," or venture capital specifically for biodiversity, and they provide funding primarily in sectors like biotechnology, nature-based solutions, and artificial intelligence. In addition to venture capital funding, Superorganism offers strategic support to entrepreneurs, connecting
Investing activity
Superorganism appears in 2 AI deals tracked by the AI Lounge deals desk. The rounds are mostly Seed, with a median round size of $6M. The most recent are Molagri (Seed, $5.8M, Oct 2026) and Deep Forestry (Seed, $3.5M (EUR 3.0M), May 2026).
Superorganism most often invests alongside Convective Capital, Y Combinator, Julian Capital and Fairpoint Capital, and the companies it backs on AI Lounge are mostly in AI.
Deals
Frequently asked questions about Superorganism
What AI companies has Superorganism invested in?
Superorganism's AI investments include Molagri and Deep Forestry. The 2 rounds on AI Lounge are listed on this page with amounts, dates and co-investors.
Where is Superorganism based?
Superorganism is based in New York, New York, United States.
What stage does Superorganism invest at?
In the rounds tracked on AI Lounge, Superorganism has invested at Seed, with a median round of $6M.
Who does Superorganism co-invest with?
Superorganism's most frequent co-investors on AI Lounge are Convective Capital (1 deal), Y Combinator (1 deal), Julian Capital (1 deal), Fairpoint Capital (1 deal) and Spatial Capital (1 deal).
How can founders reach Superorganism?
Founders on AI Lounge can see Superorganism's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Superorganism to their Investor Pipeline to track the conversation.